Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial

Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page footer’s software revision indicator was updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without changing the underlying study history shown to users.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:27.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The record history shows the addition of Revision: v3.5.2 and the removal of Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:34.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    New revision entry v3.5.0 added to the Record History and v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:12:41.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Record history shows a new revision entry (v3.4.3) and removes the previous revision (v3.4.2).
    Difference
    0.1%
    Check dated 2026-03-11T23:52:44.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added to the record history. The notice about government funding lapse and the previous Revision: v3.4.1 entry have been removed.
    Difference
    0.9%
    Check dated 2026-02-11T14:49:13.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-04T10:46:30.000Z thumbnail image

Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.